Background Pregnant and lactating women were excluded from initial coronavirus disease
2019 vaccine trials; thus, data to guide vaccine decision making are lacking. Objective This …

There is a persistent bias toward higher prevalence and increased severity of coronavirus
disease 2019 (COVID-19) in males. Underlying mechanisms accounting for this sex difference …

The availability of three COVID-19 vaccines in the United States provides an unprecedented
opportunity to examine how vaccine platforms and timing of vaccination in pregnancy …

There is limited information on the specific impact of maternal infection with the SARS-CoV-2
B.1.617.2 (delta) variant on pregnancy outcomes. We present 2 cases of intrauterine fetal …

Background Although emerging data during the SARS-CoV-2 pandemic have demonstrated
robust messenger RNA vaccine–induced immunogenicity across populations, including …

Background Expression of angiotensin-converting enzyme 2 (ACE2) and type II transmembrane
serine protease (TMPRSS2), host molecules required for viral entry, may underlie sex …

There is a persistent male bias in the prevalence and severity of COVID-19 disease.
Underlying mechanisms accounting for this sex difference remain incompletely understood. …

The SARS-CoV-2 virus activates maternal and placental immune responses, which in the
setting of other infections occurring during pregnancy are known to impact fetal brain …

Background Sex differences in vulnerability to and severity of SARS-CoV-2 infection have
been described in non-pregnant populations. ACE2 and TMPRSS2, host molecules required …

BACKGROUND While emerging data during the SARS-CoV-2 pandemic have demonstrated
robust mRNA vaccine-induced immunogenicity across populations, including pregnant and …